Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)
Phase 2
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2011-03-04
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- SBPharmaceutical IND, Co., LTD
- Target Recruit Count
- 30
- Registration Number
- NCT01308645
- Locations
- π°π·
Inha University Hospital, Incheon, Jung-gu, Korea, Republic of
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer
Phase 2
- Conditions
- Colorectal Cancer
- First Posted Date
- 2011-03-01
- Last Posted Date
- 2011-03-04
- Lead Sponsor
- SBPharmaceutical IND, Co., LTD
- Target Recruit Count
- 30
- Registration Number
- NCT01305980
- Locations
- π°π·
Inha University Hospital, Incheon, Jung-gu, Korea, Republic of
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Phase 2
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2011-03-01
- Last Posted Date
- 2011-03-01
- Lead Sponsor
- SBPharmaceutical IND, Co., LTD
- Target Recruit Count
- 20
- Registration Number
- NCT01305967
- Locations
- π°π·
Keimyung University Dongsan Hospital, Daegu, Jung-gu, Korea, Republic of
π°π·Sam Anyang Medical Center, Anyang, Man-an-gu, Korea, Republic of
π°π·Kyungpook University Hospital, Deagu, Jung-gu, Korea, Republic of
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
Phase 2
- Conditions
- Gastric Cancer
- First Posted Date
- 2011-03-01
- Last Posted Date
- 2011-03-01
- Lead Sponsor
- SBPharmaceutical IND, Co., LTD
- Target Recruit Count
- 26
- Registration Number
- NCT01305993
- Locations
- π°π·
Inha University Hospital, Incheon, Jung-gu, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath